subject: CHEBI:601027

subject_name: Aliskiren

object_name: kidney failure


subject: CHEBI:6121

subject_name: Ketamine

object_name: Thoracic Injury

tested_intervention: unsure


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: glioblastoma

tested_intervention: yes


subject: UMLS:C3827032

object_name: Childhood Glioblastoma


subject: UMLS:C3827032

object_name: adult glioblastoma


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Breast Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:6520

subject_name: Lomustine

object_name: melanoma


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947

object_name: brain cancer


subject: CHEBI:74947

object_name: brain neoplasm


subject: GTOPDB:12990

subject_name: sintilimab

object_name: sarcoma


subject: GTOPDB:12990

object_name: soft tissue sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: CHEBI:64183

subject_name: Ubiquinol

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:64183

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: pulmonary eosinophilia


subject: UNII:2P471X1Z11

object_name: Asthmatic pulmonary eosinophilia


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:6A901E312A

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:6A901E312A

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:6A901E312A

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: GTOPDB:9311

subject_name: urelumab

object_name: Neck Carcinoma


subject: GTOPDB:9311

object_name: head and neck neoplasm


subject: GTOPDB:9311

object_name: head and neck cancer


subject: GTOPDB:9311

object_name: colorectal cancer


subject: GTOPDB:9311

object_name: colorectal carcinoma


subject: GTOPDB:9311

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL1743085

subject_name: URELUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: CHEMBL.COMPOUND:CHEMBL1743085


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: UMLS:C1831875


subject: CHEBI:26708

subject_name: sodium atom

object_name: proteinuria


subject: CHEBI:26708

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:26708

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:26708

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:26708

object_name: preeclampsia


subject: CHEBI:26708

object_name: Pregnant


subject: CHEBI:26708

object_name: hypertension


subject: CHEBI:26708

object_name: Hypertension, CTCAE


subject: CHEBI:29101

subject_name: Sodium cation


subject: CHEBI:29101


subject: CHEBI:29101


subject: CHEBI:29101


subject: CHEBI:29101


subject: CHEBI:29101


subject: CHEBI:29101


subject: CHEBI:29101


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3541959


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: UMLS:C3714642


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Allergy to H+/K+-exchanging ATPase inhibitor


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: malignant pleural mesothelioma


subject: CHEBI:36467

subject_name: Ciguatoxins


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: recurrent pneumonia


subject: PR:000006592


subject: UMLS:C0251564

subject_name: Pulmozyme


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Diabetes


subject: CHEBI:17925

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:16044

subject_name: L-methionine residue


subject: CHEBI:16044


subject: UMLS:C0596383

subject_name: Copolymer

object_name: Dental Plaque


subject: CHEBI:53310

subject_name: copolymer macromolecule


subject: CHEBI:60804

subject_name: copolymer


subject: UMLS:C5773115


subject: UNII:OV18TY1BGB

object_name: EXCESS LMW-DNA


subject: CHEBI:9168

subject_name: Sirolimus

object_name: juvenile nasopharyngeal angiofibroma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: pancreatic neoplasm


subject: CHEBI:233362

object_name: exocrine pancreatic carcinoma


subject: CHEBI:233362

object_name: malignant pancreatic neoplasm


subject: CHEBI:233362

object_name: melanoma


subject: CHEBI:233362

object_name: skin melanoma


subject: UMLS:C4287737


subject: UMLS:C4287737


subject: UMLS:C4287737


subject: UMLS:C4287737


subject: UMLS:C4287737


subject: UMLS:C4527228

object_name: Childhood Solid Neoplasm


subject: UMLS:C4527228

object_name: Adult Solid Neoplasm


subject: UMLS:C4527228

object_name: Solid Neoplasm


subject: UMLS:C4527228


subject: UMLS:C4527228


subject: UMLS:C4527228


subject: UMLS:C4527228


subject: UMLS:C4527228


subject: UNII:5OGS5K699E

subject_name: Merestinib


subject: UNII:5OGS5K699E


subject: UNII:5OGS5K699E


subject: UNII:5OGS5K699E


subject: UNII:5OGS5K699E


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1831638

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831638

object_name: breast carcinoma


subject: UMLS:C1831638

object_name: breast cancer


subject: UMLS:C1831638

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C1831638

object_name: Embolism, Tumor


subject: UMLS:C1831638

object_name: Neoplasm Metastasis


subject: CHEBI:31547

subject_name: Eplerenone

object_name: primary hyperparathyroidism


subject: CHEBI:60411

subject_name: bacteriopheophytin

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:9941750

object_name: hemorrhoid


subject: PUBCHEM.COMPOUND:9941750

object_name: Hemorrhoids, CTCAE 3.0


subject: PUBCHEM.COMPOUND:9941750

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:176381

subject_name: Diosmin


subject: CHEBI:176381


subject: CHEBI:176381


subject: UMLS:C0215217

subject_name: Daflon


subject: UMLS:C0215217


subject: UMLS:C0215217


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Vulvar Cancer AJCC v8


subject: UNII:16VY3TM7ZO

object_name: Stage IV Vulvar Cancer AJCC v7


subject: UNII:16VY3TM7ZO

object_name: Stage IV Vulvar Cancer AJCC v6


subject: UNII:16VY3TM7ZO

object_name: Cervix carcinoma stage IV


subject: UNII:16VY3TM7ZO

object_name: Stage IV Cervical Cancer AJCC v6 and v7


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C0596581

subject_name: Fluoropyrimidine

object_name: colorectal cancer


subject: UMLS:C0596581

object_name: colorectal carcinoma


subject: UMLS:C0596581

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:135207

subject_name: Clofedanol

object_name: common cold


subject: CHEBI:135207

object_name: tonsillitis


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: UMLS:C5227718

object_name: focal segmental glomerulosclerosis


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: idiopathic CD4 lymphocytopenia


subject: CHEBI:3380

subject_name: Captopril

object_name: heart disorder


subject: UMLS:C0006938

subject_name: captopril


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: small cell lung carcinoma


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection


subject: UMLS:C0499127

subject_name: Injection, etoposide, 10 mg administered


subject: UMLS:C5203273

subject_name: Etoposide Liquid Injection


subject: UMLS:C5670961

subject_name: Copper Cu 64 SAR-bisPSMA

object_name: prostate neoplasm


subject: CHEBI:30956

subject_name: trichloroacetic acid

object_name: actinic cheilitis


subject: UMLS:C3536819

subject_name: Tricyclic Antidepressant [EPC]


subject: CHEBI:135954

subject_name: Bilastine

object_name: Allergy


subject: CHEBI:135954

object_name: hypersensitivity reaction disease


subject: CHEBI:135954

object_name: Emotional hypersensitivity


subject: UNII:760I9WM792

subject_name: Lasmiditan

object_name: substance abuse


subject: UNII:760I9WM792

object_name: prescription drug abuse (not dependent)


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Malignant Solid Neoplasm


subject: MESH:D056692

subject_name: Prebiotics

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:1879

subject_name: Tyrosol


subject: UMLS:C1708275

subject_name: HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine

object_name: cervical cancer


subject: UMLS:C1708275

object_name: cervical carcinoma


subject: UMLS:C1708275

object_name: pancreatic neoplasm


subject: UMLS:C1708275

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1708275

object_name: malignant pancreatic neoplasm


subject: UMLS:C1708275

object_name: colon carcinoma


subject: UMLS:C1708275

object_name: colorectal cancer


subject: UMLS:C1708275

object_name: colon cancer


subject: UMLS:C1708275

object_name: melanoma


subject: UMLS:C4077947

subject_name: Pegloxenatide

object_name: Endometrial Intraepithelial Neoplasia


subject: UMLS:C4077947

object_name: atypical endometrial hyperplasia


subject: UMLS:C4077947

object_name: infertility


subject: UMLS:C4077947

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4077947

object_name: obesity


subject: UMLS:C4077947

object_name: Obesity, CTCAE


subject: CHEBI:49668

subject_name: Gefitinib

object_name: male breast carcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: peripheral vascular disease


subject: CHEBI:192614

object_name: peripheral arterial disease


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UMLS:C3502775

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Malignant neoplasm of female breast


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:78432

object_name: Unresectable Melanoma


subject: CHEBI:78432

object_name: Advanced Melanoma


subject: CHEBI:75998

subject_name: Trametinib


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: central retinal vein occlusion


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:34730

subject_name: doxycycline hyclate

object_name: bacterial sexually transmitted disease


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:50692

subject_name: Mifepristone

object_name: incomplete abortion


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hemodynamic instability


subject: CHEBI:8404

subject_name: Prilocaine


subject: UNII:3G3529LUQ7

subject_name: PEGTIBATINASE

object_name: homocystinuria


subject: UMLS:C5446782

subject_name: Pegtibatinase


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection

object_name: metastatic melanoma


subject: UMLS:C5203423

object_name: melanoma


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: myelofibrosis


subject: CHEBI:52970

object_name: cardiac arrest


subject: CHEBI:52970

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:64183


subject: CHEBI:74705

subject_name: Met-Leu

object_name: small cell lung carcinoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Childhood Solid Neoplasm


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: Solid Neoplasm


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: non-small cell lung carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: Adult Solid Neoplasm


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: CHEBI:73604

subject_name: Lys-Gly


subject: PUBCHEM.COMPOUND:196095

subject_name: proctofoam-HC

object_name: Pregnant


subject: PUBCHEM.COMPOUND:196095

object_name: hemorrhoid


subject: PUBCHEM.COMPOUND:196095

object_name: Hemorrhoids, CTCAE 3.0


subject: PUBCHEM.COMPOUND:196095

object_name: Hemorrhoids, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: Respiratory Sounds


subject: PUBCHEM.COMPOUND:2307

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:2307

object_name: Bronchospasm


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:6832

subject_name: Methocarbamol

object_name: Ventral hernia


subject: CHEBI:6832

object_name: Inguinal hernia


subject: CHEBI:32171

subject_name: Sulthiame

object_name: epilepsy


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:71219

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:71219

object_name: metastatic melanoma


subject: CHEBI:71219

object_name: Unresectable Melanoma


subject: CHEBI:71219

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage I Childhood Retinoblastoma by Toronto Guidelines v2


subject: CHEBI:31355

object_name: Stage I Retinoblastoma


subject: CHEBI:31355

object_name: bilateral retinoblastoma


subject: CHEBI:31355

object_name: unilateral retinoblastoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan

object_name: pediatric intraocular retinoblastoma


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:135544

subject_name: Ilaprazole

object_name: Stomach cancer


subject: CHEBI:135544

object_name: gastric cancer


subject: CHEBI:15891

subject_name: Taurine

object_name: Cardiovascular Risk


subject: CHEBI:27732

subject_name: Caffeine


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: Metastatic human epidermal growth factor 2 positive carcinoma of breast


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: UNII:3CO94WO6DJ

subject_name: Eplivanserin

object_name: Insomnia, CTCAE 3.0


subject: UNII:3CO94WO6DJ

object_name: Insomnia, CTCAE 5.0


subject: UNII:3T25U84H4U

subject_name: TELOTRISTAT ETIPRATE

object_name: Hepatic impairment


subject: UMLS:C2825840

subject_name: Xermelo


subject: UMLS:C5239517

subject_name: Firastotug

object_name: Childhood Solid Neoplasm


subject: UMLS:C5239517

object_name: Adult Solid Neoplasm


subject: UMLS:C5239517

object_name: Solid Neoplasm


subject: UMLS:C2353555

subject_name: Rob 803

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:137501615

subject_name: TEBAPIVAT

object_name: Myelodysplasia


subject: DRUGBANK:DB19338

subject_name: Tebapivat


subject: UMLS:C4552074

object_name: kidney failure


subject: CHEBI:91408

subject_name: Fedratinib


subject: UMLS:C0353697

subject_name: carbidopa / levodopa

object_name: Anhedonia


subject: UMLS:C0353697

object_name: Depressed mood


subject: UMLS:C0353697

object_name: Cancer patients and suicide and depression


subject: UMLS:C0353697

object_name: Depressed - symptom


subject: UMLS:C0353697

object_name: Depression, CTCAE


subject: UMLS:C1455750

subject_name: Triticum aestivum antigen

object_name: ghrelin measurement


subject: UMLS:C1455750

object_name: obesity due to congenital leptin deficiency


subject: UMLS:C5554964

subject_name: Dodekin

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5554964

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2981842

object_name: metastatic colorectal cancer


subject: UNII:A5595LHJ2L

subject_name: Funapide

object_name: osteoarthritis, knee


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: colorectal cancer


subject: UNII:PVI5M0M1GW

object_name: colorectal carcinoma


subject: UNII:PVI5M0M1GW

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: MESH:D000074262

subject_name: Rapeseed Oil

object_name: cardiovascular disorder


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: flatfoot


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: clavicle fracture


subject: CHEBI:52172

subject_name: Nilotinib

object_name: systemic mastocytosis


subject: CHEBI:52172

object_name: disseminated eosinophilic collagen disease


subject: CHEBI:52172

object_name: Eosinophilia


subject: CHEBI:52172

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:52172

object_name: Ph-positive acute lymphoblastic leukemia


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: toxic epidermal necrolysis


subject: UNII:B72HH48FLU

object_name: Toxic Epidermal Necrolysis, CTCAE


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: maple syrup urine disease type 1A


subject: CHEBI:41500

object_name: maple syrup urine disease


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: Apathy


subject: CHEBI:8874

object_name: On examination - apathetic


subject: CHEBI:8874

object_name: No dementia


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: adult brainstem glioma


subject: UMLS:C0379528

object_name: Adult Mixed Glioma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: breast disorder


subject: CHEBI:93786


subject: UMLS:C1613953

object_name: Hepatic impairment


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: T-cell lymphoma recurrent


subject: UMLS:C4505396

subject_name: High-Dose Trivalent Influenza Vaccine

object_name: influenza


subject: UNII:97WKI06KTX

object_name: prostate carcinoma


subject: UNII:97WKI06KTX

object_name: prostate cancer


subject: CHEBI:82978

subject_name: paliperidone

object_name: bipolar disorder


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Moderate nonproliferative retinopathy due to diabetes mellitus


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Child Malnutrition


subject: PUBCHEM.COMPOUND:126456119

object_name: Wasting


subject: PUBCHEM.COMPOUND:126456119

object_name: Cachexia


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: CHEBI:83094

subject_name: (R)-lipoamide

object_name: diarrhea


subject: CHEBI:83094

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:83094

object_name: Diarrhea, CTCAE


subject: CHEBI:83094


subject: CHEBI:83094


subject: CHEBI:83094


subject: UNII:968JKA7T33

subject_name: LYSOZYME


subject: UNII:968JKA7T33


subject: UNII:968JKA7T33


subject: UNII:968JKA7T33


subject: UNII:968JKA7T33


subject: UNII:968JKA7T33


subject: PUBCHEM.COMPOUND:91976556

subject_name: Muramidase


subject: PUBCHEM.COMPOUND:91976556


subject: PUBCHEM.COMPOUND:91976556


subject: PUBCHEM.COMPOUND:91976556


subject: PUBCHEM.COMPOUND:91976556


subject: PUBCHEM.COMPOUND:91976556


subject: CHEMBL.COMPOUND:CHEMBL2108463

subject_name: GARLIC

object_name: denture stomatitis


subject: UMLS:C0885057

subject_name: garlic preparation


subject: CHEBI:81045

subject_name: lead oxide

object_name: staphylococcus aureus infection


subject: CHEBI:53450

subject_name: poly(butylene oxide) macromolecule


subject: CHEBI:61603

subject_name: poly(butylene oxide) polymer


subject: CHEBI:32687

subject_name: Piperonyl butoxide


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors

object_name: post-traumatic stress disorder


subject: UMLS:C0360105

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]


subject: UMLS:C2911696


subject: CHEBI:6121

subject_name: Ketamine

object_name: TRAUMA/INJURY PROBLEM


subject: PUBCHEM.COMPOUND:42608431

object_name: migraine


subject: PUBCHEM.COMPOUND:42608431

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C0032144

subject_name: Plasminogen Activator

object_name: Ischemic stroke


subject: UMLS:C0032144

object_name: Acute Stroke


subject: CHEBI:231694

subject_name: Serdemetan

object_name: neoplasm


subject: UMLS:C5907979

subject_name: Base Edited Natural Killer Cells NK510

object_name: colorectal cancer


subject: UMLS:C5907979

object_name: colorectal carcinoma


subject: UMLS:C5907979

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: non-Hodgkin lymphoma


subject: UMLS:C4048878

subject_name: MGCD 0103


subject: UMLS:C5205034

object_name: ovarian cancer


subject: UMLS:C5205034

object_name: ovarian carcinoma


subject: UMLS:C5205034

object_name: malignant epithelial tumor of ovary


subject: PR:000011357

subject_name: NPC intracellular cholesterol transporter 2

object_name: type 1 diabetes mellitus


subject: UniProtKB:P03114

subject_name: VE1_HPV16 Replication protein E1 (sprot)


subject: CHEBI:156296


subject: PR:000003866

subject_name: allograft inflammatory factor 1


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered

object_name: Coronavinae infectious disease


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:85993

object_name: head and neck neoplasm


subject: CHEBI:5523

subject_name: Goserelin

object_name: endometrium carcinoma in situ


subject: CHEBI:5523

object_name: endometrial cancer


subject: CHEBI:5523

object_name: hyperlipidemia


subject: CHEBI:5523

object_name: Lipidemias


subject: CHEBI:94463

object_name: chronic disease


subject: CHEBI:94463

object_name: Chronic Disease


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: helminthiasis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: stage II melanoma


subject: CHEBI:74705

object_name: skin melanoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Opioid Misuse


subject: CHEBI:3215

object_name: anxiety


subject: CHEBI:3215

object_name: anxiety disorder


subject: CHEBI:3215

object_name: Anxiety symptoms


subject: CHEBI:3215

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:3215

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:184381

subject_name: Bacitracin

object_name: Diabetic foot ulcer


subject: CHEBI:184381

object_name: type 2 diabetes mellitus


subject: CHEBI:184381

object_name: type 1 diabetes mellitus


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C2830049

object_name: Crohn disease


subject: DRUGBANK:DB18724

object_name: alpha 1-antitrypsin deficiency


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:91398

subject_name: Tivantinib

object_name: triple-negative breast carcinoma


subject: CHEBI:91398

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:91398

object_name: Carcinoma breast stage IV


subject: CHEBI:91398

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:91398

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:91398

object_name: Breast cancer recurrent


subject: CHEBI:91398

object_name: HER2/Neu Negative


subject: CHEBI:91398

object_name: Estrogen Receptor Negative


subject: CHEBI:91398

object_name: Progesterone Receptor Negative


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: Chronic uremia


subject: UMLS:C2343505

subject_name: Arcalyst


subject: CHEBI:38867

subject_name: anaesthetic

object_name: Abdominal pain


subject: CHEBI:38867

object_name: Abdominal Pain, CTCAE


subject: CHEBI:38867

object_name: Hematemesis


subject: CHEBI:38867

object_name: Heartburn


subject: CHEBI:38867

object_name: dyspepsia


subject: CHEBI:38867

object_name: Dyspepsia, CTCAE


subject: UMLS:C0002932

subject_name: Anesthetics


subject: UMLS:C0002932


subject: UMLS:C0002932


subject: UMLS:C0002932


subject: UMLS:C0002932


subject: UMLS:C0002932


subject: UMLS:C4722058

subject_name: Anesthetics [TC]


subject: UMLS:C4722058


subject: UMLS:C4722058


subject: UMLS:C4722058


subject: UMLS:C4722058


subject: UMLS:C4722058


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: thyroid gland carcinoma


subject: UMLS:C5706511

subject_name: Anti-B7-H3 Antibody-drug Conjugate YL201

object_name: nasopharyngeal carcinoma


subject: UMLS:C5706511

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: acute myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UMLS:C5706553

subject_name: Anti-HER2 Antibody-drug Conjugate BL-M07D1


subject: UMLS:C5706553

object_name: gastric adenocarcinoma


subject: CHEBI:50091

subject_name: S-Nitrosoglutathione

object_name: asthma


subject: CHEBI:3561

subject_name: Cetirizine


subject: CHEBI:167202

subject_name: nafarelin acetate

object_name: infertility


subject: PUBCHEM.COMPOUND:25077649

subject_name: Nafarelin


subject: UMLS:C0131793

subject_name: Synarel


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: immune system disorder


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: PUBCHEM.COMPOUND:23709079

subject_name: Treximet

object_name: Cognitive impairment


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:75998

subject_name: Trametinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:75998

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:28830

subject_name: Chlorambucil

object_name: adult lymphoma


subject: CHEBI:28830

object_name: lymphoma


subject: CHEBI:28830

object_name: pediatric lymphoma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: autoimmune polyendocrinopathy


subject: CHEBI:68579

object_name: EXCESS LMW-DNA


subject: CHEBI:16199

subject_name: Urea

object_name: Hand eczema


subject: PUBCHEM.COMPOUND:578771

subject_name: Betamethasone 17 Valerate


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:50730

subject_name: Montelukast

object_name: portal vein, cavernous transformation of


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: sunburn


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:132922

object_name: pharyngitis


subject: CHEBI:132922

object_name: Pharyngitis, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Renal cell carcinoma recurrent


subject: UMLS:C0379528

object_name: Renal cancer recurrent


subject: UMLS:C0379528

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C0379528

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C0379528

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C0379528

object_name: Stage III renal cell cancer


subject: UMLS:C0379528

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0379528

object_name: Recurrent Endometrial Cancer


subject: UMLS:C0379528

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C0379528

object_name: Endometrial cancer stage III


subject: UMLS:C0379528

object_name: endometrial serous adenocarcinoma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UMLS:C5907910

subject_name: Hydrogel-based Resiquimod STM-416

object_name: superficial urinary bladder carcinoma


subject: UMLS:C5555010

subject_name: HPV16 E6/7 mRNA Vaccine BNT113

object_name: head and neck neoplasm


subject: UMLS:C5555010

object_name: head and neck cancer


subject: UMLS:C5555010

object_name: cervical cancer


subject: UMLS:C5555010

object_name: uterine cervix neoplasm


subject: UMLS:C5555010

object_name: cervical polyp


subject: UMLS:C5555010

object_name: Cervical neoplasm


subject: UMLS:C5555010

object_name: HPV-related carcinoma


subject: UMLS:C5555010

object_name: penile cancer


subject: UMLS:C5555010

object_name: Unknown Primary Tumors


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Pediatric Disorder


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324

object_name: Urinary Urgency


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:177298

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:177298

object_name: castration-resistant prostate carcinoma


subject: CHEBI:177298

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:145499

subject_name: Donepezil

object_name: Dementia due to Alzheimer's disease (disorder)


subject: CHEBI:135530


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced Adult Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:6335487

object_name: Hypotension on induction


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate

object_name: bariatric surgery candidate


subject: UNII:MLM29U2X85


subject: CHEBI:89324


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: CHEBI:27300


subject: UMLS:C3537249


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:7421

subject_name: NAC

object_name: drug-induced liver injury


subject: CHEBI:73895

subject_name: Gly-D-Ser

object_name: pancreatic neoplasm


subject: CHEBI:73895

object_name: exocrine pancreatic carcinoma


subject: CHEBI:73895

object_name: malignant pancreatic neoplasm


subject: CHEBI:73895

object_name: Effects of chemotherapy


subject: CHEBI:73516

subject_name: Gly-Ser


subject: CHEBI:73516


subject: CHEBI:73516


subject: CHEBI:73516


subject: PR:000008058

subject_name: glutamine synthetase


subject: PR:000008058


subject: PR:000008058


subject: PR:000008058


subject: UMLS:C1134696


subject: UMLS:C1134696


subject: UMLS:C1134696


subject: CHEBI:125427

object_name: mouth neoplasm


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:41423

subject_name: Celecoxib


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: glycogen storage disease V


subject: UNII:953A26OA1Y

subject_name: Dornase alfa

object_name: Neutrophilic asthma


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: rheumatoid lung disease


subject: UMLS:C4548561

object_name: sickle cell disease


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form

object_name: human papilloma virus infection


subject: PR:000015975

object_name: oropharynx cancer


subject: PR:000015975

object_name: neoplasm of oropharynx


subject: UMLS:C0034790

subject_name: T-Cell Receptor


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: CHEMBL.COMPOUND:CHEMBL1743058

subject_name: PONEZUMAB

object_name: cerebral amyloid angiopathy


subject: CHEMBL.COMPOUND:CHEMBL1743058

object_name: ACys amyloidosis


subject: UMLS:C3273712

subject_name: ponezumab


subject: UMLS:C3273712


subject: UMLS:C0070359

subject_name: peptide YY (3-36)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0070359

object_name: obesity


subject: UMLS:C0070359

object_name: Obesity, CTCAE


subject: CHEBI:167574

subject_name: Semaglutide

object_name: coronary atherosclerosis


subject: CHEBI:24848

subject_name: inositol

object_name: glucose intolerance


subject: CHEBI:24848

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:24848

object_name: Insulin resistance


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:4FR53SIF3A

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:4FR53SIF3A

object_name: Blast Phase


subject: UNII:4FR53SIF3A

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:4FR53SIF3A


subject: UNII:4FR53SIF3A

object_name: BCR-ABL1 Fusion Protein Expression


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775

object_name: Philadelphia Chromosome Positive


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:78543

subject_name: Ponatinib


subject: CHEBI:78543


subject: CHEBI:44915

subject_name: Propofol

object_name: metabolic acidosis


subject: CHEBI:49575

subject_name: Diazepam

object_name: Drug Resistant Epilepsy


subject: CHEBI:32599

object_name: toxemia of pregnancy


subject: UMLS:C4733061

object_name: peritoneum cancer


subject: UMLS:C4733061

object_name: fallopian tube carcinoma


subject: UMLS:C4733061

object_name: fallopian tube cancer


subject: UMLS:C4733061

object_name: ovarian cancer


subject: UMLS:C4733061

object_name: ovarian neoplasm


subject: UMLS:C4733061

object_name: ovarian carcinoma


subject: CHEBI:76018

subject_name: Riociguat

object_name: Abnormal left ventricular function


subject: UMLS:C2717562


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Complication of prematurity


subject: CHEBI:46195

object_name: Patent ductus arteriosus - persisting type


subject: UMLS:C4527230

subject_name: Zirconium (89Zr) crefmirlimab berdoxam

object_name: multiple sclerosis


subject: UMLS:C4527230


subject: MESH:C568859

object_name: Disorder of intraocular pressure


subject: MESH:C568859

object_name: Intraocular Pressure


subject: UMLS:C5203017

subject_name: G-Series Nerve Agent GB

object_name: chronic obstructive pulmonary disease


subject: CHEBI:90531

subject_name: Sotrastaurin

object_name: choroiditis


subject: CHEBI:90531

object_name: posterior uveitis


subject: CHEBI:90531

object_name: uveitis


subject: CHEBI:90531

object_name: Uveitis, CTCAE


subject: CHEBI:90531

object_name: panuveitis


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: UNII:EPK39PL4R4

subject_name: ELASOMERAN


subject: UMLS:C5577555

subject_name: Opdualag

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5577555

object_name: clear cell renal carcinoma


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Other Dermatology or Skin, CTCAE


subject: CHEBI:3374

object_name: Pruritus, CTCAE


subject: CHEBI:3374

object_name: Pruritus


subject: CHEBI:25187

subject_name: Menthol


subject: CHEBI:25187

object_name: neuralgia


subject: CHEBI:25187

object_name: Neuropathic pain


subject: CHEBI:25187


subject: CHEBI:25187


subject: PUBCHEM.COMPOUND:53421694


subject: PUBCHEM.COMPOUND:53421694


subject: PUBCHEM.COMPOUND:53421694


subject: PUBCHEM.COMPOUND:53421694


subject: PUBCHEM.COMPOUND:53421694


subject: CHEBI:16731

subject_name: Cinnamaldehyde


subject: CHEBI:16731


subject: CHEBI:16731


subject: CHEBI:16731


subject: CHEBI:16731


subject: CHEBI:6801

subject_name: Metformin

object_name: Small cell lung cancer recurrent


subject: CHEBI:6801

object_name: small cell lung carcinoma


subject: CHEBI:6801

object_name: Small cell lung cancer extensive stage


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)


subject: CHEBI:31348

subject_name: Capecitabine

object_name: pseudomyxoma peritonei


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: neuromyelitis optica


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: heart failure


subject: UNII:3A3U0GI71G

object_name: Heart Failure, CTCAE


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: PUBCHEM.COMPOUND:152165

object_name: Breast Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:152165

object_name: Mastalgia


subject: PUBCHEM.COMPOUND:152165

object_name: BREAST PAIN FEMALE


subject: PUBCHEM.COMPOUND:152165

object_name: Breast Pain, CTCAE 3.0


subject: PUBCHEM.COMPOUND:152165

object_name: Non-cyclical mastalgia


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: UNII:G0835O03ZM

object_name: Peptic Ulcer


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: lung cancer


subject: UNII:4EQZ6YO2HI

object_name: lung neoplasm


subject: UNII:4EQZ6YO2HI

object_name: lung carcinoma


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:9150

subject_name: Simvastatin

object_name: sclerosing cholangitis


subject: CHEBI:9150

object_name: primary sclerosing cholangitis


subject: CHEBI:8499

subject_name: Propranolol

object_name: alcohol abuse


subject: CHEBI:8499

object_name: alcohol dependence


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Cardiac transplant failure


subject: PUBCHEM.COMPOUND:17753757

subject_name: Pimecrolimus

object_name: pityriasis alba


subject: CHEBI:73878

subject_name: hexadehydroastechrome

object_name: Second or third degree burns


subject: PR:000008449

subject_name: hyaluronan synthase 1


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: FIGO Stage III Ovarian Cancer 2014


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIC Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIA2 Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIA Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIA1 Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIB Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIA1(i) Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IIIA1(ii) Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IVB Ovarian Cancer 2014


subject: UNII:2S9ZZM9Q9V

object_name: FIGO Stage IVA Ovarian Cancer 2014


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:91083

subject_name: Romiplostim

object_name: hepatitis C


subject: UMLS:C1505595


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: malignant soft tissue neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Microsatellite Instability


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Uses oral contraception (finding)


subject: PR:000012938

subject_name: pinin


subject: UMLS:C1696294

subject_name: Yaz


subject: CHEBI:149785

subject_name: nelociguat

object_name: heart failure


subject: CHEBI:149785

object_name: Heart Failure, CTCAE


subject: CHEBI:133538

subject_name: Lysine

object_name: hyperglycemia


subject: CHEBI:133538

object_name: Hyperglycemia, CTCAE


subject: CHEBI:133538

object_name: Glucose in blood specimen above reference range


subject: CHEBI:133538

object_name: glucose metabolism disease


subject: CHEBI:133538

object_name: metabolic disease


subject: UMLS:C0024337

subject_name: lysine


subject: UMLS:C0024337


subject: UMLS:C0024337


subject: UMLS:C0024337


subject: UMLS:C0024337


subject: MESH:D000468

subject_name: Alkalies

object_name: Blood Pressure Finding


subject: MESH:D000468

object_name: Systemic arterial pressure


subject: MESH:D000468

object_name: body weight


subject: MESH:D000468

object_name: metabolic acidosis


subject: MESH:D000468

object_name: Extracellular alteration


subject: MESH:D000468

object_name: nephrolithiasis


subject: CHEBI:7465

subject_name: Naltrexone


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: large B-cell lymphoma


subject: UMLS:C4329313


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Carcinoma of urinary bladder, invasive


subject: UNII:UU226QGU97

subject_name: Imeglimin

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Gastrointestinal cancer metastatic


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:190410

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: CHEMBL.COMPOUND:CHEMBL2108494


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UMLS:C0733470


subject: UNII:86EEZ49YVB

subject_name: FOSTAMATINIB DISODIUM

object_name: rheumatoid arthritis


subject: UMLS:C1611320

object_name: Alzheimer disease


subject: UMLS:C5418073

subject_name: ERK1/2 Inhibitor JSI-1187

object_name: Childhood Solid Neoplasm


subject: UMLS:C5418073

object_name: Adult Solid Neoplasm


subject: UMLS:C5418073

object_name: melanoma


subject: UMLS:C5418073

object_name: non-small cell lung carcinoma


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED

object_name: systemic sclerosis


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel


subject: UNII:UG97LO5M8Y


subject: UNII:UG97LO5M8Y

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4802164

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802164

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802164

object_name: pediatric lymphoma


subject: UMLS:C4727076

subject_name: MAT2A Inhibitor AG-270


subject: UMLS:C4727076


subject: UMLS:C4727076


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C5854570

subject_name: TEAD Inhibitor BPI-460372

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:194531

subject_name: flerovium atom

object_name: pancreatic neoplasm


subject: CHEBI:194531

object_name: exocrine pancreatic carcinoma


subject: CHEBI:194531

object_name: malignant pancreatic neoplasm


subject: CHEBI:190710

subject_name: Phe-Leu


subject: CHEBI:190710


subject: CHEBI:190710


subject: CHEBI:17051

subject_name: Fluoride ion


subject: CHEBI:17051


subject: CHEBI:17051


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: cluster headache syndrome


subject: UNII:I5I8VB78VT

object_name: hypnic headache


subject: UNII:I5I8VB78VT

object_name: trigeminal autonomic cephalalgia


subject: UNII:I5I8VB78VT

object_name: brain disorder


subject: UMLS:C0879396

object_name: Mesothelioma


subject: UMLS:C0879396

object_name: mesothelial neoplasm


subject: UMLS:C0879396

object_name: malignant mesothelioma


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:9G6U5L461Q

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:9G6U5L461Q

object_name: EGFR gene mutation


subject: UMLS:C1831593

subject_name: Denenicokin

object_name: melanoma


subject: UMLS:C1831593

object_name: Embolism, Tumor


subject: UMLS:C1831593

object_name: Neoplasm Metastasis


subject: UMLS:C1831593

object_name: Metastatic Lesion


subject: UMLS:C1831593

object_name: kidney neoplasm


subject: UMLS:C1831593

object_name: kidney cancer


subject: UniProtKB:P04143

subject_name: THRSP_RAT Thyroid hormone-inducible hepatic protein (sprot)

object_name: Helicobacter pylori infection


subject: PR:000016322

subject_name: thyroid hormone-inducible hepatic protein


subject: MESH:C000631483

object_name: myositis


subject: UMLS:C3644708

subject_name: Kcentra

object_name: End stage heart disease


subject: CHEBI:5062

subject_name: Finasteride

object_name: Uses contraception (finding)


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:24848

subject_name: inositol

object_name: Squamous Lung Dysplasia


subject: CHEBI:24848

object_name: non-small cell lung carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: fallopian tube carcinoma


subject: GTOPDB:4942

object_name: fallopian tube cancer


subject: GTOPDB:4942

object_name: primary peritoneal carcinoma


subject: GTOPDB:4942

object_name: Primary Peritoneal Cancer


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: CHEBI:82941

subject_name: Fosamprenavir

object_name: Laryngopharyngeal Reflux


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Ascending aortic dissection


subject: CHEBI:230430

object_name: Acute Aortic Syndrome


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: CHEBI:17234

subject_name: D-glucose

object_name: Embolism, Tumor


subject: CHEBI:17234

object_name: Neoplasm Metastasis


subject: CHEBI:17234

object_name: Metastasis


subject: CHEBI:17234

object_name: Metastatic Lesion


subject: CHEBI:17234

object_name: brain cancer


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C0388020


subject: UMLS:C0388020


subject: UMLS:C0388020


subject: UMLS:C0388020


subject: CHEBI:68841

subject_name: Gadobutrol


subject: CHEBI:68841


subject: CHEBI:68841


subject: CHEBI:68841


subject: GTOPDB:4999

object_name: HIV infection


subject: UMLS:C0021761


subject: UMLS:C1328727


subject: CHEBI:71464

subject_name: Palmidrol

object_name: Postoperative Pain, Chronic


subject: UMLS:C4287689

subject_name: MCL-1 inhibitor AMG 176

object_name: non-Hodgkin lymphoma


subject: UMLS:C4287689

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4287689

object_name: acute myeloid leukemia


subject: UMLS:C4287689

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4287689

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C4287689

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: GTOPDB:12989

subject_name: toripalimab

object_name: nasopharyngeal neoplasm


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:10033

subject_name: Warfarin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:10033

object_name: obesity


subject: CHEBI:10033

object_name: Obesity, CTCAE


subject: UMLS:C4078262

object_name: type 2 diabetes mellitus


subject: UMLS:C0219461

subject_name: regramostim

object_name: non-small cell lung carcinoma


subject: CHEBI:16566

subject_name: sphinganine

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:90658247

subject_name: L-threo-sphinganine


subject: CHEBI:179060

subject_name: Safingol


subject: CHEBI:46968


subject: UMLS:C2587184

subject_name: Parenogen

object_name: gastric adenoma


subject: UMLS:C2587184

object_name: microinvasive gastric cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: dental phobia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: influenza


subject: UNII:A2VM2V569A

object_name: metastatic melanoma


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: esophageal squamous cell carcinoma


subject: UNII:4B93MGE4AL

object_name: esophageal adenocarcinoma


subject: UNII:4B93MGE4AL

object_name: pancreatic neoplasm


subject: UNII:4B93MGE4AL

object_name: exocrine pancreatic carcinoma


subject: UNII:4B93MGE4AL

object_name: malignant pancreatic neoplasm


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63631

subject_name: Topiramate

object_name: hyperlipidemia


subject: CHEBI:63631

object_name: hyperlipoproteinemia


subject: CHEBI:63631

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:63631

object_name: Serum lipids high (finding)


subject: CHEBI:63631

object_name: hypertriglyceridemia


subject: CHEBI:63631

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: osteoporosis


subject: CHEBI:74705

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:74705

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:74705

object_name: Osteoporosis, CTCAE 3.0


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C0003374

subject_name: Antimalarials

object_name: Uncomplicated malaria


subject: UMLS:C0003374

object_name: Plasmodium falciparum malaria


subject: UMLS:C0003374

object_name: malaria


subject: UMLS:C3652932

subject_name: pyronaridine and artesunate drug combination


subject: UMLS:C3652932


subject: CHEBI:3441

subject_name: Carvedilol

object_name: heart disorder


subject: UMLS:C3827091


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b


subject: CHEBI:6456

subject_name: Lidocaine

object_name: retinal detachment


subject: CHEBI:6456

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:6456

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Dyslipidemia


subject: CHEBI:31824

subject_name: Mesna

object_name: Refractory acute myeloid leukemia


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: aura; migraine without aura


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476

object_name: Common Migraine


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: hyperparathyroidism


subject: PUBCHEM.COMPOUND:2735

object_name: Hyperparathyroidism, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: sleep apnea


subject: UNII:420K487FSG

object_name: Sleep Apnea, CTCAE


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin

object_name: nasopharyngeal carcinoma


subject: UMLS:C5207052

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: CHEBI:32139

object_name: Abnormality of acid-base homeostasis


subject: GTOPDB:4507


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: neoplastic meningitis


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:9588

subject_name: Ticlopidine

object_name: carotid stenosis


subject: CHEBI:80270

object_name: outcomes general quality of life


subject: CHEBI:80270

object_name: Perceived quality of life


subject: CHEBI:80270

object_name: Good quality of life


subject: CHEBI:80270

object_name: Inflammation


subject: CHEBI:80270

object_name: mood (physical finding)


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: PR:000008039


subject: PR:000008039


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: PUBCHEM.COMPOUND:166177193

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:166177193

object_name: amyotrophic lateral sclerosis


subject: DRUGBANK:DB18678


subject: DRUGBANK:DB18678


subject: CHEBI:30879

subject_name: alcohol

object_name: Psychomotor Retardation


subject: CHEBI:16236

subject_name: Ethanol


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: viral pneumonia


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: opioid abuse


subject: CHEBI:5790

object_name: Addictive stimulant use


subject: CHEBI:5790

object_name: Harmful pattern of use of stimulant


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: opiate dependence


subject: CHEBI:6887


subject: CHEBI:6887


subject: CHEBI:6887


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: lichen planus, oral


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:31355

subject_name: Carboplatin

object_name: cognitive/functional effects


subject: CHEBI:31355

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775

object_name: Drug toxicity


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:32150

object_name: Childhood Breast Carcinoma


subject: CHEBI:32150

object_name: breast carcinoma


subject: CHEBI:32150

object_name: breast cancer


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:6435378

object_name: peripheral arterial disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: B-cell neoplasm


subject: CHEBI:30742

subject_name: macrogol

object_name: small intestine disorder


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Recurrent disease


subject: UNII:7XL5ISS668

object_name: Global Relapse in Viscera


subject: UNII:7XL5ISS668

object_name: Global Relapse in Lymph Nodes


subject: UNII:7XL5ISS668

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:7XL5ISS668

object_name: Global Relapse


subject: UNII:7XL5ISS668

object_name: Global Relapse in Skin


subject: UNII:7XL5ISS668

object_name: Global Relapse in Blood


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:16108

subject_name: Dihydroxyacetone phosphate

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:16108

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:16108


subject: CHEBI:16108


subject: MESH:C000621460

subject_name: fu-zheng-qu-zhuo

object_name: Stage 3 chronic kidney disease


subject: MESH:C000621460

object_name: Stage 4 chronic kidney disease


subject: CHEBI:70839

subject_name: Dasatinib

object_name: colorectal cancer


subject: CHEBI:70839

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: GTOPDB:8221

subject_name: epacadostat

object_name: gastric adenocarcinoma


subject: GTOPDB:8221


subject: GTOPDB:8221

object_name: Unresectable Esophageal Carcinoma


subject: GTOPDB:8221

object_name: recurrent gastric cancer


subject: GTOPDB:8221

object_name: Oesophageal carcinoma recurrent


subject: GTOPDB:8221

object_name: Malignant neoplasm of stomach stage IV


subject: GTOPDB:8221

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:17347

subject_name: Testosterone

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:17347

object_name: COPD, severe early onset


subject: CHEBI:17347

object_name: chronic obstructive pulmonary disease


subject: CHEBI:233413

subject_name: Denifanstat

object_name: HER2 positive breast carcinoma


subject: CHEBI:233413

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:233413

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:233413

object_name: Advanced Breast Carcinoma


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: PUBCHEM.COMPOUND:74380454

subject_name: Volixibat

object_name: primary biliary cholangitis


subject: PUBCHEM.COMPOUND:74380454

object_name: primary biliary cholangitis 1


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Acute migraine


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: acute kidney failure


subject: CHEBI:28645

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol


subject: PUBCHEM.COMPOUND:6912


subject: CHEBI:17151


subject: CHEBI:17151


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: UNII:IKE1P4X57J

subject_name: Aggrastat

object_name: Ischemic stroke


subject: GTOPDB:12900

subject_name: pozelimab

object_name: protein-losing enteropathy


subject: UNII:0JJ21K6L2I

subject_name: Pozelimab


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:768FW21J3L

object_name: Metastatic Renal Cell Cancer


subject: UNII:768FW21J3L

object_name: kidney cancer


subject: UNII:768FW21J3L

object_name: childhood kidney cell carcinoma


subject: UMLS:C2346611

subject_name: ARRY 520

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2346611

object_name: acute myeloid leukemia


subject: PR:000003045

subject_name: kinesin-like protein KIF11


subject: PR:000003045


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: glioblastoma


subject: UNII:Y6BX7BL23K

object_name: Childhood Glioblastoma


subject: UNII:Y6BX7BL23K

object_name: adult glioblastoma


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Migrainous vertigo


subject: UNII:H81695M5OP

subject_name: nattokinase

object_name: hypertension


subject: UNII:H81695M5OP

object_name: Hypertension, CTCAE


subject: UMLS:C0131956


subject: UMLS:C0131956


subject: CHEBI:7904

subject_name: Aredia

object_name: SAPHO syndrome


subject: CHEBI:7903

subject_name: Pamidronic acid


subject: UNII:I3NPL1V48Q

object_name: pancreatic neoplasm


subject: UNII:I3NPL1V48Q

object_name: exocrine pancreatic carcinoma


subject: UNII:I3NPL1V48Q

object_name: malignant pancreatic neoplasm


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: bone cancer


subject: UMLS:C3852764

object_name: bone neoplasm


subject: CHEBI:59057

subject_name: Sulfachlorpyridazine

object_name: Parkinson disease


subject: CHEBI:18246

subject_name: Cellulose


subject: PR:000013689

subject_name: sugar transporter SWEET1


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: scleroderma


subject: CHEBI:50749

object_name: systemic sclerosis


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:205919


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C5556426

subject_name: Keynatinib

object_name: B-cell neoplasm


subject: CHEBI:45783

subject_name: Imatinib

object_name: neurofibromatosis


subject: CHEBI:45783

object_name: neurofibromatosis 1


subject: CHEBI:45783

object_name: neurofibroma


subject: CHEBI:45783

object_name: neurofibromatosis type 1


subject: CHEBI:45725

object_name: Premature birth


subject: CHEBI:45725

object_name: premature birth (history)


subject: CHEBI:45725

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:45725

object_name: neuroendocrine carcinoma


subject: CHEBI:45725

object_name: necrotizing enterocolitis


subject: CHEBI:15746

subject_name: Spermine


subject: CHEBI:15746


subject: CHEBI:15746


subject: CHEBI:15746


subject: CHEBI:15746


subject: CHEBI:31824

subject_name: Mesna

object_name: childhood acute myeloid leukemia


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: malaria


subject: CHEBI:36560

subject_name: Zinc oxide

object_name: Neck Carcinoma


subject: CHEBI:36560

object_name: head and neck neoplasm


subject: CHEBI:36560

object_name: head and neck cancer


subject: CHEBI:36560

object_name: lung cancer


subject: CHEBI:36560

object_name: lung neoplasm


subject: CHEBI:36560

object_name: lung carcinoma


subject: CHEBI:36560

object_name: liver cancer


subject: CHEBI:36560

object_name: liver neoplasm


subject: CHEBI:36560

object_name: Adult Liver Carcinoma


subject: CHEBI:36560

object_name: liver carcinoma


subject: CHEBI:36560

object_name: cervical cancer


subject: CHEBI:36560

object_name: cervical carcinoma


subject: CHEBI:36560

object_name: bladder tumor


subject: CHEBI:36560

object_name: urinary bladder carcinoma


subject: CHEBI:36560

object_name: urinary bladder cancer


subject: CHEBI:36560

object_name: childhood bladder carcinoma


subject: CHEBI:36560

object_name: nicotine dependence


subject: CHEBI:36560

object_name: pancreatic neoplasm


subject: CHEBI:36560

object_name: exocrine pancreatic carcinoma


subject: CHEBI:36560

object_name: malignant pancreatic neoplasm


subject: CHEBI:36560

object_name: carcinoma of esophagus


subject: CHEBI:36560

object_name: esophageal cancer


subject: CHEBI:36560

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:36560

object_name: neoplasm of esophagus


subject: CHEBI:36560

object_name: Stomach cancer


subject: CHEBI:36560

object_name: gastric cancer


subject: CHEBI:36560

object_name: renal carcinoma


subject: CHEBI:36560

object_name: kidney neoplasm


subject: CHEBI:36560

object_name: kidney cancer


subject: CHEBI:36560

object_name: leukemia


subject: CHEBI:36560

object_name: childhood leukemia


subject: UMLS:C5777349

subject_name: bevacizumab ophthalmic

object_name: central retinal vein occlusion


subject: CHEBI:27082

subject_name: trehalose

object_name: Machado-Joseph disease


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic malignant neoplasm to liver


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY


subject: UMLS:C4283130

subject_name: Nigella sativa seed extract


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Refractory Thrombocytopenia


subject: PUBCHEM.COMPOUND:135449332

object_name: connective tissue disorder


subject: UMLS:C0762110

object_name: Well male adult


subject: CHEBI:231425

subject_name: tolvaptan


subject: PUBCHEM.COMPOUND:141729870

subject_name: Anlotinib (hydrochloride)

object_name: cervical polyp


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride


subject: CHEBI:67357

subject_name: Dolastatin 10


subject: CHEBI:67357


subject: CHEBI:67357


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: asthma


subject: CHEBI:291342

subject_name: Desloratadine


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:41879

object_name: Acute heart failure


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: psoriasis-related juvenile idiopathic arthritis


subject: UNII:FU77B4U5Z0

object_name: juvenile idiopathic arthritis


subject: UMLS:C4331002

subject_name: Personalized Peptide Cancer Vaccine NEO-PV-01

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: UMLS:C1310652

subject_name: Importal

object_name: female infertility


subject: UMLS:C2974550

object_name: HIV infection


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: familial partial lipodystrophy


subject: UMLS:C0592533

subject_name: Foradil

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: central nervous system cancer


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: Malignant neoplasm of the central nervous system


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: Childhood Neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: sarcoma


subject: UMLS:C5242457

subject_name: Omburtamab


subject: UMLS:C5242457


subject: UMLS:C5242457


subject: UMLS:C5242457


subject: UMLS:C5242457


subject: UMLS:C5242457


subject: CHEBI:6121

subject_name: Ketamine

object_name: Musculoskeletal Pain


subject: CHEBI:50848

subject_name: Loteprednol

object_name: xerophthalmia


subject: GTOPDB:2943

subject_name: secretin

object_name: pancreatic intraductal papillary-mucinous neoplasm


subject: CHEBI:232390


subject: CHEBI:8887

subject_name: Rofecoxib

object_name: colorectal cancer


subject: CHEBI:8887

object_name: colorectal carcinoma


subject: CHEBI:8887

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:2WTV10SIKH

subject_name: Mitapivat

object_name: kidney disorder


subject: CHEBI:6121

object_name: pancreatic neoplasm


subject: CHEBI:6121

object_name: exocrine pancreatic carcinoma


subject: CHEBI:6121

object_name: malignant pancreatic neoplasm


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: primary biliary cholangitis


subject: UMLS:C0378942


subject: CHEBI:119486

subject_name: Efavirenz

object_name: HCV coinfection


subject: CHEBI:82960

subject_name: Raltegravir


subject: CHEBI:35674

subject_name: antihypertensive agent

object_name: Cerebral hypoperfusion


subject: CHEBI:35674

object_name: orthostatic hypotension


subject: CHEBI:35674

object_name: Frailty


subject: CHEBI:35674

object_name: Irritable heart


subject: CHEBI:35674

object_name: neurocirculatory asthenia


subject: CHEBI:35674

object_name: Senile dementia


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: UMLS:C0003364


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: chronic hepatitis C virus infection


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate

object_name: contrast-induced nephropathy


subject: CHEBI:230570


subject: GTOPDB:10013

object_name: psoriatic arthritis


subject: UMLS:C4053675

subject_name: AbGn 168H


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:125354

object_name: Adult Mixed Glioma


subject: CHEBI:125354

object_name: adult pineoblastoma


subject: CHEBI:125354

object_name: adult medulloblastoma


subject: CHEBI:125354

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: CHEBI:125354

object_name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:125354

object_name: Adult Oligodendroglial Tumor


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:231594

subject_name: Norgestrel

object_name: early pregnancy


subject: CHEBI:231594

object_name: pregnancy related


subject: CHEBI:50692

subject_name: Mifepristone


subject: CHEBI:31225

subject_name: Antipyrine

object_name: infectious otitis media


subject: CHEBI:31225

object_name: Acute otitis media


subject: MESH:C411004

subject_name: FloSeal Matrix

object_name: Hemorrhage


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Paresis


subject: CHEBI:65353

object_name: Muscle weakness


subject: CHEBI:65353

object_name: Sepsis


subject: CHEBI:65353

object_name: Sepsis, CTCAE


subject: UNII:349552KRHK

subject_name: Simendan

object_name: acute respiratory distress syndrome


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: PUBCHEM.COMPOUND:48175

subject_name: Halobetasol Propionate

object_name: psoriasis


subject: PUBCHEM.COMPOUND:78383862

subject_name: Halobetasol


subject: CHEBI:135782

subject_name: ulobetasol propionate


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Depressed mood


subject: CHEBI:27306

object_name: Cancer patients and suicide and depression


subject: CHEBI:27306

object_name: Depressed - symptom


subject: CHEBI:27306

object_name: Depression, CTCAE


subject: CHEBI:73579

subject_name: Leu-Val

object_name: Childhood Solid Neoplasm


subject: CHEBI:73579

object_name: Adult Solid Neoplasm


subject: CHEBI:73579

object_name: Solid Neoplasm


subject: CHEBI:194537

subject_name: Livermorium


subject: CHEBI:194537


subject: CHEBI:194537


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: UMLS:C1881413


subject: UMLS:C1881413


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: PR:000003915


subject: PR:000003915


subject: UMLS:C2830207


subject: UMLS:C2830207


subject: UMLS:C2830207


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Myocardial bridge of coronary artery


subject: CHEBI:2668

object_name: coronary microvascular disorder


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019

object_name: Angina pectoris


subject: CHEBI:64019

object_name: Variant Angina


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: diabetes mellitus


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: Waldenstrom macroglobulinemia


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Malignant Solid Neoplasm


subject: CHEBI:131174

subject_name: Navitoclax

object_name: Unresectable Melanoma


subject: CHEBI:131174

object_name: metastatic melanoma


subject: CHEBI:131174

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:131174

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:131174


subject: CHEBI:75998

subject_name: Trametinib


subject: UNII:YRY1GG3QHU

subject_name: IMMUCIN

object_name: plasma cell myeloma


subject: UMLS:C4721548

subject_name: Immucin


subject: PUBCHEM.COMPOUND:131751089

subject_name: Majoroside F6

object_name: Critical Illness


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:8382

subject_name: Prednisone

object_name: type 2 diabetes mellitus


subject: CHEBI:8382

object_name: Diabetes


subject: CHEBI:8382


subject: CHEBI:8382

object_name: arteriosclerosis disorder


subject: CHEBI:8382

object_name: atherosclerosis


subject: CHEBI:8382

object_name: Dyslipidemia


subject: DRUGBANK:DB16537

subject_name: Bacillus clausii

object_name: gastroenteritis


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: diabetic foot


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:SFW1D987QV

subject_name: Ferrous bisglycinate

object_name: Pregnant


subject: UNII:SFW1D987QV

object_name: Iron deficiency


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline

object_name: Hepatic impairment


subject: UMLS:C4507249


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: lung cancer


subject: UNII:2285XW22DR

object_name: lung neoplasm


subject: UNII:2285XW22DR

object_name: lung carcinoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:61399

subject_name: Canertinib

object_name: breast neoplasm


subject: UMLS:C0964184


subject: CHEBI:61080

subject_name: Romidepsin

object_name: leukemia


subject: CHEBI:61080

object_name: childhood leukemia


subject: CHEBI:61080

object_name: Myelodysplasia


subject: CHEBI:61080

object_name: myeloproliferative neoplasm


subject: CHEBI:61080


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Increased reactive oxygen species production


subject: UMLS:C4687479

subject_name: Tidutamab

object_name: small cell lung carcinoma


subject: UMLS:C4687479

object_name: trabecular adenocarcinoma


subject: UMLS:C4687479

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C1176324

object_name: plasma cell myeloma


subject: CHEBI:142708

object_name: end stage renal failure


subject: CHEBI:142708

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: KEGG.COMPOUND:C00374

subject_name: Heparin


subject: KEGG.COMPOUND:C00374


subject: CHEBI:231681

subject_name: olaratumab

object_name: prostate carcinoma


subject: CHEBI:231681

object_name: prostate cancer


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: fragile X syndrome


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: MESH:C000593201

subject_name: ginseol K-g1

object_name: Prehypertension


subject: UNII:KV1M7Q3CBP

object_name: Adult Solid Neoplasm


subject: UNII:KV1M7Q3CBP

object_name: Plexosarcoma


subject: UNII:KV1M7Q3CBP

object_name: Childhood Gastrointestinal Stromal Tumor


subject: UNII:41XGO0VS1U

object_name: adult acute myeloid leukemia


subject: UNII:41XGO0VS1U

object_name: childhood acute myeloid leukemia


subject: UNII:41XGO0VS1U

object_name: acute myeloid leukemia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Complication of transplanted liver


subject: UNII:2S9ZZM9Q9V

object_name: Osteosarcoma recurrent


subject: UNII:B93608MTGW

object_name: type 2 diabetes mellitus


subject: UNII:B93608MTGW

object_name: Diabetes


subject: UNII:B93608MTGW

object_name: diabetes mellitus


subject: UNII:B93608MTGW

object_name: hypertension


subject: UNII:B93608MTGW

object_name: Hypertension, CTCAE


subject: UNII:B93608MTGW

object_name: Dyslipidemia


subject: UMLS:C1134664

object_name: mycosis fungoides


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Stress


subject: UMLS:C0086351

subject_name: Polycose

object_name: sarcopenia


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:64677

subject_name: Cerubidine


subject: UNII:A4LY1V9F0H

subject_name: DENENICOKIN

object_name: cancer


subject: UMLS:C1831593

subject_name: Denenicokin


subject: CHEBI:94534

subject_name: olanzapine

object_name: Schizophrenia and related disorders


subject: CHEBI:8871

subject_name: Risperidone


subject: UMLS:C1095911

subject_name: wheat preparation

object_name: Sicca Syndrome


subject: UMLS:C1095911

object_name: Non-celiac gluten sensitivity


subject: DRUGBANK:DB10579

subject_name: Wheat


subject: DRUGBANK:DB10579


subject: CHEBI:24433

subject_name: group


subject: CHEBI:24433


subject: UMLS:C4287724

object_name: age-related macular degeneration


subject: CHEBI:44915

subject_name: Propofol

object_name: Propofol overdose


subject: CHEBI:71952

subject_name: Dactolisib

object_name: Childhood Solid Neoplasm


subject: CHEBI:71952

object_name: Adult Solid Neoplasm


subject: CHEBI:71952

object_name: Solid Neoplasm


subject: CHEBI:71952

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2830125


subject: UMLS:C2830125


subject: UMLS:C2830125


subject: UMLS:C2830125


subject: CHEBI:145371

subject_name: Binimetinib


subject: UNII:E9M363811V

object_name: recurrent adult acute myeloid leukemia


subject: UMLS:C3490747


subject: UNII:5OGS5K699E

subject_name: Merestinib


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Infection


subject: UNII:71M78END5S

object_name: Infection of musculoskeletal system


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:145371


subject: CHEBI:145371

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:145371

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:145371

object_name: anaplastic astrocytoma


subject: CHEBI:145371

object_name: High grade glioma


subject: CHEBI:145371

object_name: glioblastoma


subject: CHEBI:145371

object_name: Childhood Glioblastoma


subject: CHEBI:145371

object_name: adult glioblastoma


subject: CHEBI:145371

object_name: Adult Gliosarcoma


subject: CHEBI:145371

object_name: gliosarcoma


subject: CHEBI:145371

object_name: Childhood Gliosarcoma


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UMLS:C3827062

object_name: Childhood Solid Neoplasm


subject: UMLS:C3827062

object_name: Adult Solid Neoplasm


subject: UMLS:C3827062

object_name: Solid Neoplasm


subject: UNII:R22TMY97SG

object_name: pancreatic neoplasm


subject: UNII:R22TMY97SG

object_name: exocrine pancreatic carcinoma


subject: UNII:R22TMY97SG

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:53387035

subject_name: Pradigastat

object_name: kidney failure


subject: UMLS:C4045958


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Cervix carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: cervical squamous cell carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: MESH:C000716749

object_name: adult lymphoma


subject: MESH:C000716749

object_name: lymphoma


subject: MESH:C000716749

object_name: pediatric lymphoma


subject: UniProtKB:C4NYP8

subject_name: F10A1_DROME Hsc70-interacting protein 1 (sprot)

object_name: patellofemoral pain syndrome


subject: UMLS:C1654726

subject_name: heme iron polypeptide


subject: PR:000013871

subject_name: regenerating islet-derived protein 3-alpha


subject: UniProtKB:P0A6Y1

subject_name: IHFB_ECOLI Integration host factor subunit beta (sprot)


subject: PR:000008541

subject_name: hedgehog-interacting protein


subject: PR:000015677

subject_name: Hsc70-interacting protein


subject: PR:000022999

subject_name: integration host factor subunit beta


subject: CHEBI:23965

subject_name: estradiol

object_name: Vaginal ulcer


subject: CHEBI:51368

subject_name: Lofexidine

object_name: substance-related disorder


subject: MESH:C000626184

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:132222602

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:132222602

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:132222602

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:132222602

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:132222602

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:132222602

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:132222602

object_name: neoplasm of esophagus


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: UNII:V6Q7413SA8


subject: PUBCHEM.COMPOUND:9884233

subject_name: ALBUTEROL SULFATE

object_name: childhood onset asthma


subject: PUBCHEM.COMPOUND:9884233

object_name: Pediatric Obesity


subject: PUBCHEM.COMPOUND:9884233

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:50733

subject_name: nutraceutical

object_name: preeclampsia


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: metastatic malignant neoplasm in the brain


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:33375

subject_name: Gadolinium

object_name: primary brain neoplasm


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993

object_name: brain cancer


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: glucose intolerance


subject: CHEBI:25681

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:25681

object_name: Increased reactive oxygen species production


subject: CHEBI:25681

object_name: Lack of sufficient daily physical activity


subject: CHEBI:25681

object_name: glucose metabolism disease


subject: CHEBI:25681

object_name: metabolic disturbance


subject: CHEBI:25681

object_name: inherited lipid metabolism disorder


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:18145


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C1452745

object_name: liver carcinoma


subject: UMLS:C1452745

object_name: hepatitis A


subject: UMLS:C1452745

object_name: hepatitis


subject: UMLS:C1452745

object_name: cholestasis


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: extramammary Paget disease


subject: CHEBI:172923

object_name: cutaneous Paget disease


subject: UMLS:C4287683

object_name: non-small cell lung carcinoma


subject: UMLS:C4287683

object_name: MET gene amplification


subject: UMLS:C4287683

object_name: MET Gene Mutation


subject: UMLS:C4287683

object_name: neoplasm


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: colorectal neoplasm


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: bladder tumor


subject: CHEBI:141969

object_name: urinary bladder carcinoma


subject: CHEBI:141969

object_name: urinary bladder cancer


subject: CHEBI:141969

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: UMLS:C5854393

subject_name: Anti-PD-1 Monoclonal Antibody QL1604

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: pulmonary embolism


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: CHEBI:31237

subject_name: Vesnarinone

object_name: Kaposi Sarcoma


subject: CHEBI:3745

subject_name: clindamycin

object_name: cellulitis


subject: CHEBI:3745

object_name: cellulitis on exam (physical finding)


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Brain Neoplasm


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570

object_name: ependymoma


subject: CHEBI:135381

subject_name: Trofosfamide


subject: CHEBI:135381


subject: CHEBI:135381

object_name: medulloblastoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: anesthesia; adverse effect, spinal and epidural


subject: CHEBI:60802

object_name: Anaesthetic complication neurological


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: polyostotic fibrous dysplasia


subject: UNII:4988K7X26P

object_name: McCune-Albright syndrome


subject: CHEBI:2567

subject_name: Alendronic acid


subject: CHEBI:2567


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Eosinophilic gastritis or gastroenteritis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C0885849

subject_name: bearberry preparation

object_name: cystitis


subject: UMLS:C0885849

object_name: Cystitis, CTCAE


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Malignant neoplasm of female breast


subject: UMLS:C3540795

object_name: Hormone receptor positive malignant neoplasm of breast


subject: UMLS:C0935796

subject_name: Annamycin Liposomal

object_name: Childhood Breast Carcinoma


subject: UMLS:C0935796

object_name: breast carcinoma


subject: UMLS:C0935796

object_name: breast cancer


subject: CHEBI:6931

subject_name: Midazolam

object_name: Anesthetics adverse reaction


subject: PUBCHEM.COMPOUND:20594489

subject_name: Bremelanotide

object_name: hypoactive sexual desire disorder


subject: UMLS:C1311125


subject: CHEBI:50692

subject_name: Mifepristone

object_name: prostate neoplasm


subject: CHEBI:50692

object_name: Recurrent ovarian cancer


subject: CHEBI:50692

object_name: non-small cell lung carcinoma


subject: CHEBI:50692

object_name: transitional cell carcinoma


subject: CHEBI:50692

object_name: malignant soft tissue neoplasm


subject: CHEBI:50692

object_name: sarcoma


subject: CHEBI:94688

subject_name: Acipimox

object_name: glucose metabolism disease


subject: CHEBI:94688

object_name: hypopituitarism


subject: CHEBI:94688

object_name: Hypopituitarism, CTCAE


subject: CHEBI:94688

object_name: metabolic disease


subject: CHEBI:94688

object_name: pituitary gland disorder


subject: CHEBI:94688

object_name: endocrine system disorder


subject: CHEBI:94688

object_name: brain disorder


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: chronic granulomatous disease


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: CHEBI:41791

subject_name: calyculin A


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4754493

object_name: Carcinoma breast stage IV


subject: UNII:L46P54NB4V


subject: UNII:L46P54NB4V


subject: UMLS:C5239320

subject_name: CK1alpha/CDK7/CDK9 Inhibitor BTX-A51


subject: UMLS:C5239320


subject: DRUGBANK:DB18776

subject_name: (R)-etodolac

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Frontal balding


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: pain agnosia


subject: UMLS:C5203471

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:3367

object_name: mismatch repair cancer syndrome 1


subject: PUBCHEM.COMPOUND:3367

object_name: Turcot syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: Mismatch Repair Deficiency


subject: PUBCHEM.COMPOUND:3367

object_name: neuroendocrine neoplasm


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: Mesothelioma


subject: PR:000001151

object_name: mesothelial neoplasm